Avidity Partners Management LP

Name: Avidity Partners Management LP: Form 13F holdings for the quarter ended 2026-06-30
Creator: Listed

An institutional investment manager in DALLAS, TX. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1791827.

Share this page

Link

Story card, 1080 × 1920

Reported value$624.4m
Positions45

Holdings: 45 positions

The filing on sec.gov

As filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.

Avidity Partners Management LP, holdings
Issuer	Class	CUSIP	Reported value$m	Weight	Shares	Change on the quarter before
Dianthus Therapeutics IncDNTH	COM	252828108	205	32.8%	2,104,184	Unchanged
CG Oncology IncCGON	COM	156944100	99.4	15.9%	1,398,948	Added+110,000
Oruka Therapeutics IncORKA	COM	687604108	72.4	11.6%	760,424	Unchanged
Jade Biosciences IncJBIO	COM NEW	008064206	37.8	6.1%	1,700,708	Added+300,000
Enliven Therapeutics IncELVN	COM	29337E102	27.9	4.5%	550,000	Added+150,000
Perspective Therapeutics IncCATX	COM NEW	46489V302	21.5	3.4%	6,299,999	Added+250,000
Aktis Oncology IncAKTS	COM	01021M104	15.6	2.5%	484,200	Added+15,634
Palvella Therapeutics Inc NePVLA	COM	697947109	10.7	1.7%	70,000	Unchanged
Mobia Med IncMOBI	COMMON STOCK	60705V103	10.7	1.7%	798,282	New+798,282
Repligen CorpRGEN	COM	759916109	10.6	1.7%	77,800	Unchanged
Immunic IncIMUX	COM NEW	4525EP200	10.3	1.6%	669,941	New+669,941
Senseonics Holdings IncSENS	COM	81727U303	9.1	1.5%	1,600,000	New+1,600,000
Karyopharm Therapeutics IncKPTI	COM NEW	48576U205	9.0	1.4%	924,487	Added+460,746
Teva Pharmaceutical Inds Ltd	SPONSORED ADS	881624209	6.8	1.1%	200,000	Unchanged
Dexcom IncDXCM	COM	252131107	6.7	1.1%	100,000	Added+10,000
Tempus Ai IncTEM	CL A	88023B103	6.1	1.0%	105,000	Added+40,000
Medtronic plc	SHS	G5960L103	5.5	0.9%	70,000	Reduced−30,000
VIR Biotechnology IncVIR	COM	92764N102	5.3	0.8%	519,300	Reduced−430,700
Structure Therapeutics IncGPCR	SPONSORED ADS	86366E106	5.3	0.8%	98,000	Added+68,000
Encompass Health CorpEHC	COM	29261A100	4.2	0.7%	42,000	Unchanged
Tenax Therapeutics IncTENX	COM NEW	88032L605	3.9	0.6%	265,934	Added+50,000
Nuvectis Pharma IncNVCT	COM	67080T108	3.7	0.6%	200,000	New+200,000
Insulet CorpPODD	COM	45784P101	3.7	0.6%	24,000	Added+14,000
Boston Scientific CorpBSX	COM	101137107	3.4	0.5%	80,000	Added+20,000
Satellos Bioscience IncMSLE	COM	80401L803	3.0	0.5%	387,769	Unchanged
Alamar Biosciences IncALMR	COMMON STOCK	010911105	3.0	0.5%	110,000	New+110,000
Context Therapeutics IncCNTX	COM	21077P108	2.8	0.4%	4,998,267	Unchanged
Gilead Sciences IncGILD	COM	375558103	2.5	0.4%	20,000	Unchanged
Charles Riv Labs International IncCRL	COM	159864107	2.3	0.4%	10,000	Unchanged
Phathom Pharmaceuticals IncPHAT	COM	71722W107	2.2	0.3%	200,000	Reduced−49,390
Avalyn Pharmaceuticals IncAVLN	COM SHS	05348Y105	2.0	0.3%	60,000	New+60,000
Kailera Therapeutics IncKLRA	COMMON STOCK	482931102	1.8	0.3%	80,000	New+80,000
Genmab A/SGMAB	SPONSORED ADS	372303206	1.4	0.2%	50,000	Unchanged
Intellia Therapeutics IncNTLA	COM	45826J105	1.3	0.2%	75,000	Unchanged
Corvus Pharmaceuticals IncCRVS	COM	221015100	1.2	0.2%	80,000	Reduced−35,000
Oddity Tech Ltd	SHS CL A	M7518J104	1.1	0.2%	70,000	Unchanged
Scynexis IncSCYX	COM	811292309	1.1	0.2%	260,206	New+260,206
Evommune IncEVMN	COM SHS	30054Y107	1.0	0.2%	75,000	New+75,000
Abbott LaboratoriesABT	COM	002824100	0.9	0.1%	10,000	Unchanged
Bridgebio Pharma IncBBIO	COM	10806X102	0.7	0.1%	10,000	Unchanged
Peloton Interactive IncPTON	CL A COM	70614W100	0.6	<0.1%	100,000	Reduced−100,000
Legend Biotech CorpLEGN	SPONSORED ADS	52490G102	0.4	<0.1%	15,000	Unchanged
Bridgebio Oncology TherapeutBBOT	COM NEW	107924102	0.3	<0.1%	43,853	Unchanged
Savara IncSVRA	COM	805111101	0.3	<0.1%	50,000	Unchanged
Trevi Therapeutics IncTRVI	COM	89532M101	0.1	<0.1%	6,660	Unchanged

Sold out: 26 positions

Held at the end of the quarter before and not reported this quarter.

Avidity Partners Management LP, positions sold out
Issuer	Class	CUSIP	Weight	Change on the quarter before
Abivax Sa-AdrABVX	SPONSORED ADS	00370M103	0.0%	Sold out−10,000
Acadia PharmACAD	COM	004225108	0.0%	Sold out−12,967
Acadia Pharmaceuticals IncACAD	COM	004225108	0.0%	Sold out−12,967
Anteris Technologies GlobalAVR	COM	03675P102	0.0%	Sold out−150,000
Anteris Technologies GlobalAVR	COM	03675P102	0.0%	Sold out−150,000
Arbutus Biopharma CorpABUS	COM	03879J100	0.0%	Sold out−125,000
Arbutus Biopharma CorpABUS	COM	03879J100	0.0%	Sold out−125,000
Centene CorpCNC	COM	15135B101	0.0%	Sold out−70,000
Corcept TheraCORT	COM	218352102	0.0%	Sold out−30,000
Corcept Therapeutics IncCORT	COM	218352102	0.0%	Sold out−30,000
Hims & Hers Health IncHIMS	COM CL A	433000106	0.0%	Sold out−50,000
Hims & Hers Health IncHIMS	COM CL A	433000106	0.0%	Sold out−75,000
Humana IncHUM	COM	444859102	0.0%	Sold out−25,000
Icon plc	SHS	G4705A100	0.0%	Sold out−16,000
Icon plc	SHS	G4705A100	0.0%	Sold out−16,000
Immunic Inc	COM	4525EP101	0.0%	Sold out−669,941
Immunic Inc	COM	4525EP101	0.0%	Sold out−6,699,411
Kenvue Inc OrdKVUE	COM	49177J102	0.0%	Sold out−100,000
Moonlake ImmunotherapeuticsMLTX	CLASS A ORD	61559X104	0.0%	Sold out−50,000
Moonlake ImmunotherapeuticsMLTX	CLASS A ORD	61559X104	0.0%	Sold out−50,000
Natera IncNTRA	COM	632307104	0.0%	Sold out−9,000
Natera IncNTRA	COM	632307104	0.0%	Sold out−9,000
Revolution Medicines IncRVMD	COM	76155X100	0.0%	Sold out−15,000
Scynexis Inc	COM NEW	811292200	0.0%	Sold out−2,081,660
Scynexis Inc	COM NEW	811292200	0.0%	Sold out−2,081,660
Unitedhealth GRPUNH	COM	91324P102	0.0%	Sold out−3,800

Source: SEC EDGAR, Form 13F-HR, accession 0001791827-26-000005 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.